Evolution of platelets in chronic hepatitis C infected patients and advanced liver fibrosis after direct-acting antiviral treatment

被引：0
|
作者：
Saez-Royuela, F. [1 ]
Linares, P. [2 ]
Calvo, S. [3 ]
Martin, I. [4 ]
Almohalla, C. [5 ]
Jorquera, F. [2 ,6 ,7 ]
Ramos, H. [1 ]
De Benito, M. [5 ]
Bernad, B. [1 ]
Alvarez, B. [2 ]
Aranda, E. B. [1 ]
机构：
[1] Hosp Univ Burgos, Burgos, Spain
[2] Complejo Asistencial Univ Leon, Leon, Spain
[3] Hosp Univ Burgos, Fdn Burgos Invest Salud, Burgos, Spain
[4] Hosp Univ Salamanca, Salamanca, Spain
[5] Hosp Univ Rio Hortega, Valladolid, Spain
[6] CIBERehd, Madrid, Spain
[7] IBIOMEDLeon, Leon, Spain
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)30943-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-276
引用
收藏
页码：S311 / S312
页数：2
相关论文
共 50 条
  • [31] New direct-acting antiviral agents for the treatment of chronic hepatitis C in 2014
    Cornberg, M.
    Siederdissen, C. Hoener Zu
    Maasoumy, B.
    Manns, M. P.
    INTERNIST, 2014, 55 (04): : 390 - +
  • [32] Direct-acting Antiviral Agents for the Treatment of Chronic Hepatitis C Virus Infection
    Kanda, Tatsuo
    Nakamoto, Shingo
    Nakamura, Masato
    Jiang, Xia
    Miyamura, Tatsuo
    Wu, Shuang
    Yokosuka, Osamu
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2014, 2 (01) : 1 - 6
  • [33] Liver transplantation for Hepatitis C patients in the era of direct-acting antiviral treatment: An evolving revolution - An invited commentary on "Liver transplantation for Hepatitis C patients in the era of direct-acting antiviral treatment: A retrospective cohort study" Comment
    Purcell, Laura N.
    Charles, Anthony
    INTERNATIONAL JOURNAL OF SURGERY, 2020, 76 : 48 - 48
  • [34] Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-acting antiviral treatment
    Niu, Bin
    Zang, Wenqian
    Zhou, Hui
    Mi, Yuqiang
    Lu, Chengzhen
    Li, Ping
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [35] Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-acting antiviral treatment
    Bin Niu
    Wenqian Zang
    Hui Zhou
    Yuqiang Mi
    Chengzhen Lu
    Ping Li
    BMC Gastroenterology, 23
  • [36] Hepatocellular carcinoma after direct-acting antiviral drug treatment in patients with hepatitis C virus
    Kogiso, Tomomi
    Sagawa, Takaomi
    Kodama, Kazuhisa
    Taniai, Makiko
    Katagiri, Satoshi
    Egawa, Hiroto
    Yamamoto, Masakazu
    Tokushige, Katsutoshi
    JGH OPEN, 2019, 3 (01): : 52 - 60
  • [37] Angiopoietin-2 as a predictor of fibrosis regression in chronic hepatitis C virus patients after direct-acting antiviral drugs
    Amira Isaac
    Tarek Maged El Sakaty
    Sarah Hamdan Hussein
    Hany Samir Rasmy
    The Egyptian Journal of Internal Medicine, 2021, 33
  • [38] Angiopoietin-2 as a predictor of fibrosis regression in chronic hepatitis C virus patients after direct-acting antiviral drugs
    Isaac, Amira
    El Sakaty, Tarek Maged
    Hussein, Sarah Hamdan
    Rasmy, Hany Samir
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2021, 33 (01):
  • [39] Impact of direct-acting antiviral agents on liver function in patients with chronic hepatitis C virus infection
    Toyoda, H.
    Berhane, S.
    de Groot, E.
    Tada, T.
    Kumada, T.
    Irving, W.
    Johnson, P.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S530 - S530
  • [40] Outcomes in Hepatitis C Positive Liver Transplantation: Timing of Direct-Acting Antiviral Treatment and Impact on Graft Fibrosis
    Wellington, Jennifer
    Ma, Andrew
    Kottilil, Shyam
    Ravichandran, Bharath
    Husson, Jennifer
    Bruno, David
    Wilson, Eleanor
    VIRUSES-BASEL, 2021, 13 (09):
12345